New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
07:47 EDTDSCODiscovery Labs receives new U.S. patent for pulmonary surfactant formulations
Discovery Laboratories announced it has received a patent issued by the United States Patent and Trademark Office entitled "Pulmonary Surfactant Formulations." The claims of the patent provide coverage for synthetic pulmonary surfactant compositions comprising a combination of a proprietary synthetic peptide and various lipids. The patent term expires in December 2028.
News For DSCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 1, 2015
07:37 EDTDSCODiscovery Labs notified by NASDAQ of minimum bid price requirement noncompliance
Discovery Laboratories received a letter from The Nasdaq Stock Market indicating that, because the company's common stock has not maintained a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, the company is no longer in compliance with Nasdaq's Minimum Bid Price Requirement Listing Rule. The company has until December 28 to regain compliance with the Requirement. If during the grace period, the company's common stock achieves a minimum closing bid price of at least $1.00 per share for a period of at least ten consecutive business days, the company will regain compliance with the Minimum Bid Price Requirement and its common stock will continue to be eligible for listing on the Nasdaq Capital Market. The company may be eligible for an additional grace period through June 27, 2016.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use